NBIX
Neurocrine Biosciences Inc
NASDAQ: NBIX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$131.23
+2.43% today
Updated 2026-04-29
Market cap
$13.20B
P/E ratio
28.10
P/S ratio
4.61x
EPS (TTM)
$4.67
Dividend yield
—
52W range
$108 – $160
Volume
1.1M
Neurocrine Biosciences Inc (NBIX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.23M | $1.22M | $3.98M | $2.95M | $33.50M | $77.41M | $53.14M | $2.92M | $0.00 | $19.77M | $15.00M | $161.63M | $451.24M | $788.10M | $1.05B | $1.13B | $1.49B | $1.89B | $2.36B | $2.86B |
| Revenue growth (YoY) | — | -96.9% | +224.8% | -25.7% | +1034.5% | +131.1% | -31.4% | -94.5% | -100.0% | — | -24.1% | +977.5% | +179.2% | +74.7% | +32.7% | +8.4% | +31.3% | +26.8% | +24.8% | +21.4% |
| Cost of revenue | $132.49M | $103.16M | $65.87M | $44.88M | $42.99M | $41.72M | $11.60M | $13.80M | $14.40M | $33.80M | $35.90M | $1.25M | $4.89M | $7.40M | $10.10M | $14.30M | $23.20M | $39.70M | $34.00M | $52.10M |
| Gross profit | $39.23M | $1.22M | $3.98M | $2.95M | $33.50M | $77.41M | $41.54M | $-10.88M | $-14.40M | $19.77M | $15.00M | $160.37M | $446.35M | $780.70M | $1.04B | $1.12B | $1.47B | $1.85B | $2.32B | $2.81B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 78.2% | -372.8% | — | 100.0% | 100.0% | 99.2% | 98.9% | 99.1% | 99.0% | 98.7% | 98.4% | 97.9% | 98.6% | 98.2% |
| R&D | $97.68M | $81.98M | $55.54M | $33.72M | $31.15M | $30.95M | $37.16M | $39.25M | $46.42M | $81.49M | $94.29M | $91.83M | $160.52M | $200.00M | $275.00M | $328.10M | $463.80M | $565.00M | $731.10M | $1.02B |
| SG&A | $54.87M | $37.48M | $20.24M | $14.83M | $16.07M | $12.54M | $13.44M | $13.35M | $17.99M | $32.48M | $68.08M | $169.91M | $248.93M | $354.06M | $433.30M | $583.30M | $752.70M | $851.60M | $816.20M | $1.16B |
| Operating income | $-113.32M | $-212.24M | $-87.30M | $-53.67M | $-13.72M | $33.92M | $1.45M | $-49.68M | $-64.41M | $-94.20M | $-147.37M | $-131.36M | $36.90M | $72.30M | $163.00M | $102.50M | $249.00M | $250.90M | $570.50M | $619.10M |
| Operating margin | -288.8% | -17340.0% | -2196.2% | -1817.5% | -41.0% | 43.8% | 2.7% | -1701.9% | — | -476.5% | -982.5% | -81.3% | 8.2% | 9.2% | 15.6% | 9.0% | 16.7% | 13.3% | 24.2% | 21.6% |
| EBITDA | $-102.75M | $-202.84M | $-73.98M | $-47.93M | $-12.29M | $34.62M | $2.10M | $-49.01M | $-63.58M | $-87.92M | $-139.64M | $-120.62M | $40.92M | $85.90M | $148.10M | $138.10M | $264.60M | $416.10M | $639.70M | $666.60M |
| EBITDA margin | -261.9% | -16571.7% | -1861.1% | -1623.2% | -36.7% | 44.7% | 4.0% | -1678.9% | — | -444.7% | -930.9% | -74.6% | 9.1% | 10.9% | 14.2% | 12.2% | 17.8% | 22.0% | 27.2% | 23.3% |
| EBIT | $-113.32M | $-212.24M | $-81.59M | $-51.11M | $-13.72M | $33.92M | $1.45M | $-49.68M | $-64.41M | $-88.93M | $-141.14M | $-123.02M | $36.90M | $78.45M | $139.50M | $127.20M | $249.00M | $394.80M | $612.60M | $636.50M |
| Interest expense | $3.72M | $3.92M | $7.03M | $7.03M | $7.03M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $19.52M | $30.53M | $32.00M | $32.80M | $25.80M | $7.10M | $4.60M | $126.60M | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-107.20M | $-207.30M | $-88.61M | $-51.04M | $-7.97M | $37.57M | $5.03M | $-46.09M | $-60.54M | $-88.93M | $-141.09M | $-142.54M | $21.11M | $37.00M | $407.30M | $89.60M | $154.50M | $249.70M | $341.30M | $478.60M |
| Net income growth (YoY) | — | -93.4% | +57.3% | +42.4% | +84.4% | +571.5% | -86.6% | -1017.2% | -31.4% | -46.9% | -58.7% | -1.0% | +114.8% | +75.3% | +1000.8% | -78.0% | +72.4% | +61.6% | +36.7% | +40.2% |
| Profit margin | -273.2% | -16936.2% | -2229.3% | -1728.3% | -23.8% | 48.5% | 9.5% | -1579.0% | — | -449.8% | -940.6% | -88.2% | 4.7% | 4.7% | 38.9% | 7.9% | 10.4% | 13.2% | 14.5% | 16.7% |